The forecasted standardized rate of HIV-AIDS mortality among women in the US remains constant at 800 deaths per hundred women annually from 2024 through 2028. This stability indicates no anticipated increase or decrease in female mortality rates related to HIV-AIDS over the coming years. Since 2023 actual data points are not provided, the year-on-year variation remains uncalculated for forecasted data.
Future trends to watch for include potential advances in HIV treatment and education, which could impact these mortality rates. Monitoring healthcare policy changes and access to healthcare services will also be essential to evaluate their influence on these trends over time.
